Better Buy: Biogen Inc. vs. Gilead Sciences

Historically, Biogen (NASDAQ: BIIB) has definitely been a better stock than Gilead Sciences (NASDAQ: GILD). Whether you look at the last three, five, 10, 25 years, or even so far in 2017, Biogen has outperformed Gilead.

But for investors, the future matters a whole lot more than the past. Which of these two big biotech stocks is the better pick going forward? Here's how Biogen and Gilead Sciences compare.

Image source: Getty Images.

Continue reading


Source: Fool.com